Table 1. Baseline Participant Characteristics by Treatment Groupa.
| Dextrose | Saline | P Valueb | |
|---|---|---|---|
| Non-Diagnostic Characteristics | |||
| No. | 19 | 16 | |
| Female | 6 (32) | 5 (31) | 0.983 |
| Age years | 54 ± 8.9 | 54 ± 12.8 | 0.960 |
| Pain duration years | 8.6 ± 6.6 | 12.9 ± 13.7 | 0.230 |
| NRS pain | 6.3 ± 1.3 | 7.1 ± 1.2 | 0.086 |
| ODI 2.0 | 43.2 ± 14.2 | 39.8 ± 13.4 | 0.477 |
| BMI | 30.8 ± 8.7 | 29.1 ± 5.2 | 0.509 |
| Narcotic Intake | 10 (53) | 8 (50) | 0.877 |
| SSRI/SNRI | 2 (11) | 1 (6) | 0.566 |
| Gabapentin/pregabalin | 3 (16) | 2 (13) | 0.585 |
| Epidural Steroid | 3 (16) | 4 (25) | 0.398 |
| Diagnostic Categories | |||
| Lumbar spinal stenosis | 8 (42) | 3 (19) | 0.195 |
| Lumbar radiculopathy | 6 (32) | 3 (19) | |
| Peripheral neuropathy | 0 | 2 (12) | |
| Post Laminectomy | 2 (10) | 2 (12) | |
| Nonspecific low back pain | 3 (16) | 6 (38) | |
aValues are expressed as No. (%) or mean ± SD.
bP values obtained from ANOVA for numeric variables. For non-numeric variables the Pearson chi square results were utilized except when cell counts were less than 5, in which case the Fisher’s exact test results were used.